Education
About Us
Working with TipRanks
Follow Us
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
Total Valuation
ABVC BioPharma has a market cap or net worth of $37.14M. The enterprise value is $23.95M.
Market Cap$37.14M
Enterprise Value$23.95M
Share Statistics
ABVC BioPharma has 25,440,407 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,440,407
Owned by Insiders―
Owned by Institutions0.05%
Financial Efficiency
ABVC BioPharma’s return on equity (ROE) is -0.71 and return on invested capital (ROIC) is -42.64%.
Return on Equity (ROE)-0.71
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-42.64%
Return on Capital Employed (ROCE)-0.48
Revenue Per Employee49.75K
Profits Per Employee0.00
Employee Count16
Asset Turnover0.04
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ABVC BioPharma is ―. ABVC BioPharma’s PEG ratio is 0.05.
PE Ratio―
PS Ratio62.24
PB Ratio4.46
Price to Fair Value4.46
Price to FCF-16.56
Price to Operating Cash Flow118.83
PEG Ratio0.05
Income Statement
In the last 12 months, ABVC BioPharma had revenue of 795.95K and earned -7.91M in profits. Earnings per share was 0.13.
Revenue795.95K
Gross Profit795.95K
Operating Income-7.15M
Pretax Income-8.35M
Net Income-7.91M
EBITDA-6.65M
Earnings Per Share (EPS)0.13
Cash Flow
In the last 12 months, operating cash flow was 291.62K and capital expenditures 0.00, giving a free cash flow of 291.62K billion.
Operating Cash Flow291.62K
Free Cash Flow291.62K
Free Cash Flow per Share0.01
Dividends & Yields
ABVC BioPharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.68
52-Week Price Change131.75%
50-Day Moving Average1.86
200-Day Moving Average2.48
Relative Strength Index (RSI)41.86
Average Volume (3m)95.05K
Important Dates
ABVC BioPharma upcoming earnings date is Mar 27, 2026, Before Open (Confirmed).
Last Earnings DateNov 17, 2025
Next Earnings DateMar 27, 2026
Ex-Dividend Date―
Financial Position
ABVC BioPharma as a current ratio of 0.41, with Debt / Equity ratio of 31.25%
Current Ratio0.41
Quick Ratio0.41
Debt to Market Cap0.07
Net Debt to EBITDA-0.42
Interest Coverage Ratio-17.20
Taxes
In the past 12 months, ABVC BioPharma has paid 24.15K in taxes.
Income Tax24.15K
Effective Tax Rate>-0.01
Enterprise Valuation
ABVC BioPharma EV to EBITDA ratio is -7.87, with an EV/FCF ratio of -17.49.
EV to Sales65.74
EV to EBITDA-7.87
EV to Free Cash Flow-17.49
EV to Operating Cash Flow-17.52
Balance Sheet
ABVC BioPharma has $745.83K in cash and marketable securities with $3.47M in debt, giving a net cash position of -$2.73M billion.
Cash & Marketable Securities$745.83K
Total Debt$3.47M
Net Cash-$2.73M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$0.57
Margins
Gross margin is 100.00%, with operating margin of -898.46%, and net profit margin of -993.60%.
Gross Margin100.00%
Operating Margin-898.46%
Pretax Margin-1049.41%
Net Profit Margin-993.60%
EBITDA Margin-835.03%
EBIT Margin-898.46%
Analyst Forecast
The average price target for ABVC BioPharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast56.52%
EPS Growth Forecast75.22%